Maharashtra FDA India mandates disclosure of cheese analogues

INDIA – The Maharashtra Food and Drugs Administration (FDA) has mandated that all food service establishments clearly disclose the use of cheese analogues in their offerings.

This latest dairy policy development in India reflects growing regulatory attention to food authenticity and consumer awareness across the dairy sector.

The directive applies to restaurants, hotels, caterers and fast-food operators, requiring them to display the information on both printed menus and digital display boards. The compliance deadline is April 30, with strict enforcement beginning May 1.

The decision follows multiple consumer complaints, highlighting that several outlets were serving cheese analogue products without proper disclosure. In many cases, these items were marketed under names that resembled traditional dairy products, such as paneer or cheese, creating confusion among buyers.

This issue has gained prominence in recent dairy news in India, particularly as consumers become more conscious of dairy nutrition news and ingredient transparency. With the rise of value-added dairy products and alternatives, clear differentiation has become essential to maintain trust.

The FDA has clarified an important distinction: paneer and cheese are derived entirely from milk and cheese analogue, on the other hand, is made using edible oils, starch, emulsifiers and other non-milk ingredients.

While the regulator has stated that these analogue products are not harmful, it emphasised that consumers must have access to accurate information to make informed dietary choices. This aligns with broader Indian dairy trends, where awareness and demand for authenticity are steadily increasing.

The directive has been issued under the Food Safety and Standards Act, 2006. Non-compliance could invite penalties under existing food safety regulations, signalling stricter enforcement in the milk industry news landscape.

FDA orders recall of 250,000 cheese due to contamination in USA

In 2025, the United States Food and Drug Administration (FDA) issued a recall of 250,000 boxes of shredded cheese due to possible metal fragment contamination.

The manufacturer, Great Lakes Cheese Co., initiated the recall after discovering metal fragments in raw materials supplied by third-party vendors.

The recall, classified as Class II, poses a moderate health risk to consumers. These products were distributed under various retail brands, including Good & Gather (Target), Great Value (Walmart), and Happy Farms (Aldi), and were available in over 30 states, including California, Florida, and New York, as well as Puerto Rico.

This mass recall underscores potential vulnerabilities in the quality control processes of private label suppliers. Despite the recall beginning in October, the FDA has kept the status as ‘ongoing’ as of December, meaning recovery efforts are still active in retail channels.

To receive our email newsletters with the latest news and insights from Africa, the Middle East and around the world,